Browse Data and Analysis

In September 2024, a National Assembly member submitted a draft revision of the Act on Transboundary Movements of Living Modified Organisms, commonly referred to as the LMO Act.

On July 26, 2016, Côte d’Ivoire enacted its national Biosafety Law No. 2016-553. This law establishes the groundwork for managing genetically engineered (GE) products.

Korea has not finalized the May 2021 revisions of its Living Modified Organism (LMO) Act, which defines Korea’s regulatory policies for products developed through innovative technologies including genome editing.

The push for the move toward biotechnology in Cote d'Ivoire began in June of 2015, when the government of Cote d'Ivoire (GOCI) adopted and ratified the Cartagena Protocol.

On July 26, 2016, Cote d’Ivoire announced the implementation of the national biosafety law after its adoption by parliament. Although the country is in the early stages of adopting agricultural biotechnology, its biosafety law is the foundation on which the country will manage the approval processes, risk management, containment, and labelling for genetically engineered (GE) products developed domestically or by a third country.

The Republic of Korea (ROK) has joined international commitments to reach carbon neutrality by 2050 and passed a Carbon Neutrality Act in 2021 to promote green growth. Although the agricultural industry will be relatively less impacted than some other sectors (including energy), agricultural producers will need to make some adjustments.

While still in the early stages for adopting genetically engineered products, the Government of Cote d’Ivoire is putting systems in place to eventually allow GE products onto the market.

Korea is in the process of revising its existing Living Modified Organism (LMO) Act to cover products of innovative biotechnologies, including genome edited products.

Korea is in the process of drafting a proposal to revise its existing Living Modified Organism (LMO) Act to cover products of innovative biotechnologies, including genome edited products.

In April 2019, the Rural Development Administration (RDA) announced the creation of its Center to Commercialize New Breeding Technologies.

This report provides minimal updates compared to the previous year’s report.

After 10 years under the Living Modified Organism (LMO) Act, Korea plans to improve and revise the LMO Act to address stakeholders’ concerns.